Phadke; Avinash S.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Phadke; Avinash S..The latest application filed is for "macrocyclic compounds for treatment of medical disorders".

Company Profile

17.38.49

Phadke; Avinash S. - Branford CT
Phadke; Avinash S. - Santa Barbara CA
Phadke; Avinash S. - Goleta CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Pharmaceutical compounds for treatment of medical disorders Grant 11,447,465 - Wiles , et al. September 20, 2	2022-09-20
Aryl, heteroaryl, and heterocyclic compounds for treatment of immune and inflammatory disorders Grant 11,407,738 - Wiles , et al. August 9, 2	2022-08-09
Macrocyclic Compounds For Treatment Of Medical Disorders App 20210300934 - WILES; Jason Allan ; et al.	2021-09-30
Aryl, Heteroaryl, And Heterocyclic Compounds For Treatment Of Medical Disorders App 20210269458 - WILES; Jason Allan ; et al.	2021-09-02
Aryl, heteroaryl, and heterocyclic pharmaceutical compounds for treatment of medical disorders Grant 11,084,800 - Wiles , et al. August 10, 2	2021-08-10
Macrocyclic compounds for treatment of medical disorders Grant 11,053,253 - Wiles , et al. July 6, 2	2021-07-06
Disubstituted compounds for treatment of medical disorders Grant 11,001,600 - Wiles , et al. May 11, 2	2021-05-11
Amino Compounds For Treatment Of Immune And Inflammatory Disorders App 20210122733 - WILES; Jason Allan ; et al.	2021-04-29
Amide Compounds For Treatment Of Immune And Inflammatory Disorders App 20210115034 - Wiles; Jason Allan ; et al.	2021-04-22
Amide compounds for treatment of immune and inflammatory disorders Grant 10,919,884 - Wiles , et al. February 16, 2	2021-02-16
Amino compounds for treatment of immune and inflammatory disorders Grant 10,906,887 - Wiles , et al. February 2, 2	2021-02-02
Aryl, heteroaryl, and heterocyclic compounds for treatment of medical disorders Grant 10,822,352 - Wiles , et al. November 3, 2	2020-11-03
Compounds for treatment of immune inflammatory disorders Grant 10,807,952 - Wiles , et al. October 20, 2	2020-10-20
Aryl, Heteroaryl, And Heterocyclic Compounds For Treatment Of Immune And Inflammatory Disorders App 20200262818 - Wiles; Jason Allan ; et al.	2020-08-20
Aryl, heteroaryl, and heterocyclic compounds for treatment of immune and inflammatory disorders Grant 10,662,175 - Wiles , et al.	2020-05-26
Amino compounds for treatment of medical disorders Grant 10,660,876 - Wiles , et al.	2020-05-26
Aryi, Heteroaryl, and Heterocyclic Pharmaceutical Compounds for Treatment of Medical Disorders App 20200071301 - Wiles; Jason Allan ; et al.	2020-03-05
Aryl, Heteroaryl, And Heterocyclic Compounds For Treatment Of Complement Mediated Disorders App 20200062790 - Wiles; Jason Allan ; et al.	2020-02-27
Ether compounds for treatment of complement mediated disorders Grant 10,550,140 - Wiles , et al. Fe	2020-02-04
Macrocyclic Compounds For Treatment Of Medical Disorders App 20200002347 - Wiles; Jason Allan ; et al.	2020-01-02
Pharmaceutical Compounds For Treatment Of Medical Disorders App 20190382376 - Wiles; Jason Allan ; et al.	2019-12-19
Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disorders Grant 10,464,956 - Wiles , et al. No	2019-11-05
Amide compounds for treatment of complement mediated disorders Grant 10,428,094 - Wiles , et al. October 1, 2	2019-10-01
Compounds for treatment of complement mediated disorders Grant 10,428,095 - Wiles , et al. October 1, 2	2019-10-01
Ether compounds for treatment of medical disorders Grant 10,385,097 - Wiles , et al. A	2019-08-20
Carbamate, ester, and ketone compounds for treatment of complement mediated disorders Grant 10,370,394 - Wiles , et al.	2019-08-06
Aryl, Heteroaryl, And Heterocyclic Compounds For Treatment Of Medical Disorders App 20190211033 - Wiles; Jason Allan ; et al.	2019-07-11
Aryl, Heteroaryl, And Heterocyclic Compounds For Treatment Of Complement Mediated Disorders App 20190185498 - Wiles; Jason Allan ; et al.	2019-06-20
Aryl, heteroaryl, and heterocyclic compounds for treatment of medical disorders Grant 10,287,301 - Wiles , et al.	2019-05-14
Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disorders Grant 10,253,053 - Wiles , et al.	2019-04-09
Ether Compounds For Treatment Of Complement Mediated Disorders App 20190048033 - Wiles; Jason Allan ; et al.	2019-02-14
Compounds For Treatment Of Complement Mediated Disorders App 20190031692 - Wiles; Jason Allan ; et al.	2019-01-31
Amino compounds for treatment of complement mediated disorders Grant 10,189,869 - Gadhachanda , et al. Ja	2019-01-29
Aryl, Heteroaryl, And Heterocyclic Compounds For Treatment Of Complement Mediated Disorders App 20190023729 - Wiles; Jason Allan ; et al.	2019-01-24
Amide compounds for treatment of medical disorders Grant 10,138,225 - Wiles , et al. Nov	2018-11-27
Aryl, Heteroaryl, And Heterocyclic Compounds For Treatment Of Medical Disorders App 20180305375 - Wiles; Jason Allan ; et al.	2018-10-25
Ether compounds for treatment of complement mediated disorders Grant 10,106,563 - Wiles , et al. October 23, 2	2018-10-23
Alkyne Compounds for Treatment of Complement Mediated Disorders App 20180298043 - Wiles; Jason Allan ; et al.	2018-10-18
Alkyne Compounds For Treatment Of Complement Mediated Disorders App 20180291046 - Wiles; Jason Allan ; et al.	2018-10-11
Alkyne Compounds For Treatment Of Complement Mediated Disorders App 20180291047 - Wiles; Jason Allan ; et al.	2018-10-11
Compounds for the treatment of medical disorders Grant 10,092,584 - Wiles , et al. October 9, 2	2018-10-09
Compounds for treatment of complement mediated disorders Grant 10,087,203 - Wiles , et al. October 2, 2	2018-10-02
Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disorders Grant 10,081,645 - Wiles , et al. September 25, 2	2018-09-25
Compounds For Treatment Of Immune Inflammatory Disorders App 20180201580 - Wiles; Jason Allan ; et al.	2018-07-19
Amide Compounds For Treatment Of Immune And Inflammatory Disorders App 20180186782 - Wiles; Jason Allan ; et al.	2018-07-05
Aryl, heteroaryl, and heterocyclic compounds for treatment of medical disorders Grant 10,011,612 - Wiles , et al. July 3, 2	2018-07-03
Aryl, Heteroaryl, And Heterocyclic Compounds For Treatment Of Immune And Inflammatory Disorders App 20180179186 - Wiles; Jason Allan ; et al.	2018-06-28
Amino Compounds For Treatment Of Immune And Inflammatory Disorders App 20180179185 - Wiles; Jason Allan ; et al.	2018-06-28
Disubstituted Compounds For Treatment Of Medical Disorders App 20180179236 - Wiles; Jason Allan ; et al.	2018-06-28
Amino Compounds For Treatment Of Medical Disorders App 20180177761 - Wiles; Jason Allan ; et al.	2018-06-28
Amide compounds for treatment of complement mediated disorders Grant 10,005,802 - Wiles , et al. June 26, 2	2018-06-26
Phosphonate compounds for treatment of medical disorders Grant 10,000,516 - Wiles , et al. June 19, 2	2018-06-19
Alkyne Compounds For Treatment Of Complement Mediated Disorders App 20180072762 - Wiles; Jason Allan ; et al.	2018-03-15
Aryl, Heteroaryl, And Heterocyclic Compounds For Treatment Of Complement Mediated Disorders App 20180030075 - Wiles; Jason Allan ; et al.	2018-02-01
Compounds for Treatment of Complement Mediated Disorders App 20180022767 - Wiles; Jason Allan ; et al.	2018-01-25
Ether Compounds For Treatment Of Complement Mediated Disorders App 20180022766 - Wiles; Jason Allan ; et al.	2018-01-25
Alkyne compounds for treatment of complement mediated disorders Grant 9,828,396 - Wiles , et al. November 28, 2	2017-11-28
Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disorders Grant 9,796,741 - Gadhachanda , et al. October 24, 2	2017-10-24
Amide Compounds For Treatment Of Complement Mediated Disorders App 20170298084 - Wiles; Jason Allan ; et al.	2017-10-19
Carbamate, Ester, And Ketone Compounds For Treatment Of Complement Mediated Disorders App 20170298085 - Wiles; Jason Allan ; et al.	2017-10-19
Compounds for treatment of complement mediated disorders Grant 9,758,537 - Wiles , et al. September 12, 2	2017-09-12
Carbamate, ester, and ketone compounds for treatment of complement mediated disorders Grant 9,732,103 - Wiles , et al. August 15, 2	2017-08-15
Ether compounds for treatment of complement mediated disorders Grant 9,732,104 - Gadhachanda , et al. August 15, 2	2017-08-15
Amino Compounds for Treatment of Complement Mediated Disorders App 20170189410 - Gadhachanda; Venkat Rao ; et al.	2017-07-06
Amide compounds for treatment of complement mediated disorders Grant 9,695,205 - Wiles , et al. July 4, 2	2017-07-04
Phosphonate compounds for treatment of complement mediated disorders Grant 9,663,543 - Wiles , et al. May 30, 2	2017-05-30
Amino compounds for treatment of complement mediated disorders Grant 9,598,446 - Gadhachanda , et al. March 21, 2	2017-03-21
Aryl, Heteroaryl, and Heterocyclic Compounds for Treatment of Medical Disorders App 20170066783 - Wiles; Jason Allan ; et al.	2017-03-09
Phosphonate Compounds for Treatment of Medical Disorders App 20170057983 - Wiles; Jason Allan ; et al.	2017-03-02
Compounds for the Treatment of Medical Disorders App 20170056428 - Wiles; Jason Allan ; et al.	2017-03-02
Ether Compounds for Treatment of Medical Disorders App 20170057993 - Wiles; Jason Allan ; et al.	2017-03-02
Amide Compounds for Treatment of Medical Disorders App 20170057950 - Wiles; Jason Allan ; et al.	2017-03-02
Phosphonate Compounds For Treatment Of Complement Mediated Disorders App 20160362432 - Wiles; Jason Allan ; et al.	2016-12-15
Compounds For Treatment Of Complement Mediated Disorders App 20160361329 - Wiles; Jason Allan ; et al.	2016-12-15
Amide Compounds For Treatment Of Complement Mediated Disorders App 20160362398 - Wiles; Jason Allan ; et al.	2016-12-15
Ether Compounds For Treatment Of Complement Mediated Disorders App 20160362433 - Wiles; Jason Allan ; et al.	2016-12-15
Aryl, Heteroaryl, And Heterocyclic Compounds For Treatment Of Complement Mediated Disorders App 20160362399 - Wiles; Jason Allan ; et al.	2016-12-15
Amide Compounds for Treatment of Complement Mediated Disorders App 20150239893 - Wang; Qiuping ; et al.	2015-08-27
Aryl, Heteroaryl, and Heterocyclic Compounds for Treatment of Complement Mediated Disorders App 20150239895 - Gadhachanda; Venkat Rao ; et al.	2015-08-27
Ether Compounds for Treatment of Complement Mediated Disorders App 20150239920 - Gadhachanda; Venkat Rao ; et al.	2015-08-27
Phosphonate Compounds for Treatment of Complement Mediated Disorders App 20150239921 - Wiles; Jason Allan ; et al.	2015-08-27
Compounds for Treatment of Complement Mediated Disorders App 20150239838 - Phadke; Avinash S. ; et al.	2015-08-27
Alkyne Compounds for Treatment of Complement Mediated Disorders App 20150239868 - Pais; Godwin ; et al.	2015-08-27
Carbamate, Ester, and Ketone Compounds for Treatment of Complement Mediated Disorders App 20150239919 - Gadhachanda; Venkat Rao ; et al.	2015-08-27
Amino Compounds for Treatment of Complement Mediated Disorders App 20150239894 - Gadhachanda; Venkat Rao ; et al.	2015-08-27
Indium photosensitizers for PDT Grant 6,444,194 - Robinson , et al. September 3, 2	2002-09-03
Method for the demethoxycarbonylation of porphyrinic compounds such as pheophorbides Grant 5,973,141 - Robinson , et al. October 26, 1	1999-10-26

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.